Nordson Earnings Reports

Nordson delivered a strong fourth quarter, with slight revenue growth and notable improvements in earnings and free cash flow conversion, despite headwinds from divestitures and mixed performance across segments.

Nordson Corporation reported a robust third quarter with 12% year-over-year sales growth to $742 million. Adjusted EPS rose 13% to $2.73, driven by strong performance in Advanced Technology Solutions and Medical and Fluid Solutions. Free cash flow conversion reached 180%, reflecting operational strength and efficient capital use.

Nordson reported a 5% increase in sales year-over-year for the second quarter of fiscal 2025, reaching $683 million. Diluted earnings per share were $1.97, while adjusted earnings per diluted share rose 3% to $2.42. EBITDA also saw a 7% increase, reaching $217 million.

Nordson Corporation reported Q1 FY25 revenue of $615 million, a 2.8% decline year-over-year. Net income was $95 million, with EPS at $1.65 and adjusted EPS at $2.06. Despite lower organic sales, backlog grew 15% during the quarter, and order entry showed signs of improvement.

Nordson Corporation reported a 4% increase in sales to $744 million for the fiscal fourth quarter ended October 31, 2024. Adjusted earnings per diluted share were $2.78, and the Atrion Medical acquisition integration is progressing well.

Nordson Corporation reported a 2% increase in sales to $662 million for the third quarter of fiscal year 2024. Earnings per diluted share were $2.04, and adjusted earnings per diluted share were $2.41. The company is increasing its full-year revenue guidance and tightening its adjusted earnings per diluted share guidance.

Nordson Corporation reported second quarter fiscal 2024 results with sales of $651 million, net income of $118 million, and adjusted earnings per diluted share of $2.34. The company is updating its full-year fiscal 2024 revenue guidance to the range of flat to 2% growth and adjusted earnings per diluted share to the range of $9.35 to $9.75 per share.

Nordson Corporation reported a 4% increase in sales, reaching $633 million, and a net income of $110 million. The adjusted earnings per diluted share increased by 3% to $2.21. The company is narrowing its full-year revenue growth to 4% to 7%.

Nordson Corporation reported a 5% increase in sales to $719 million and a record EBITDA of $227 million for the fourth quarter of fiscal year 2023. The company's performance was driven by strong growth in medical interventional solutions, industrial coatings, and polymer processing product lines, which offset weakness in electronics dispense and biopharma product lines. Adjusted earnings per diluted share were $2.46, compared to $2.44 in the prior year.

Nordson Corporation reported a 2% decrease in sales to $649 million for the third quarter of fiscal year 2023, with a net income of $128 million, or $2.22 per share. Despite the sales dip, the company maintained strong profitability with an EBITDA of $208 million, representing 32% of sales. The team remains focused on the execution of our Ascend strategy to achieve top tier growth with leading margins and returns.

Nordson Corporation reported a 2% increase in sales, reaching $650 million. The company's EPS was $2.21, with an adjusted EPS of $2.26. The organic sales increase was driven by strong 7% growth in Asia Pacific. Diversification of business helped offset sales decreases in semiconductor and biopharmaceutical end markets, with a strong EBITDA of 31%.

Nordson Corporation reported first quarter fiscal 2023 results with sales of $610 million, a 1% organic increase over the prior year. Adjusted earnings per share were $1.95 compared to $2.07 in the prior year. The company is updating its full-year fiscal 2023 revenue growth guidance to 0% to 3% and adjusted earnings guidance to $8.75 to $9.50 per share.

Nordson Corporation reported a strong fourth quarter with sales of $684 million, a 14% year-over-year increase, and earnings of $2.44 per diluted share, a 30% increase from the prior year. The company's full-year sales, operating profit, and earnings per share were all company records.

Nordson Corporation reported record third-quarter results with sales of $662 million, a 2% increase over the prior year. Earnings per share were $2.45, and adjusted earnings per share were $2.49, a 3% increase year-over-year. The company is confirming its full-year fiscal 2022 guidance with revenue growth of 8% to 9% and adjusted earnings per diluted share growth of 18% to 21%.

Nordson Corporation reported an 8% increase in sales, reaching $635 million, and an 11% increase in operating profit, totaling $184 million. Adjusted earnings per share were $2.43, a 15% increase over the prior year. The company is raising its full-year earnings guidance and narrowing revenue growth expectations.

Nordson Corporation reported a strong first quarter for fiscal year 2022, with sales of $609 million, a 16% increase over the prior year. Earnings per share were $2.05, and adjusted earnings per diluted share were $2.07, a 57% increase over the prior year. The company is updating its full-year 2022 guidance to the high-end of the range for revenue and earnings.

Nordson Corporation reported a 7% year-over-year increase in sales, reaching $599 million with 10% organic growth. Operating profit was $151 million, representing 25% of sales, and earnings per diluted share increased by 18% to $1.88.

Nordson Corporation reported record third-quarter results with sales of $647 million, a 20% increase year-over-year. Operating profit increased by 57% to $188 million, and earnings per share rose by 70% to $2.42. The company raised its full-year revenue and earnings guidance, expecting continued strength in order entry and backlog.

Nordson Corporation reported record second-quarter results with sales reaching $590 million, an 11% increase over the prior year. Operating profit increased by 33% to $166 million, and earnings per share rose by 34% to $2.12. The company raised its fiscal year 2021 earnings guidance range by approximately 13% to $7.20 to $7.50 per diluted share.

Nordson Corporation reported a 6% increase in sales to $527 million and a 48% increase in earnings per share to $1.32 for the fiscal first quarter ended January 31, 2021. The growth was driven by strength in consumer non-durable and industrial end markets. The company expects full year sales growth of 4% to 6% and diluted earnings per share in the range of $6.30 to $6.70.

Nordson Corporation reported a 5% year-over-year decrease in sales to $559 million for the fourth quarter of fiscal year 2020. Earnings per share (EPS) were $0.31, while adjusted EPS was $1.59, an 11% decrease from the prior year. The company's performance was affected by weakness in industrial and automotive end markets, offset by strength in test and inspection product lines.

Nordson Corporation reported a 4% year-over-year decrease in sales, totaling $538 million for the third quarter of fiscal year 2020. Earnings per diluted share were $1.49, while adjusted earnings per diluted share were $1.42, a 12% decrease from the prior year. The sales decrease was primarily organic, with the acquisition of Fluortek being offset by unfavorable currency impacts.

Nordson Corporation reported sales of $529 million, a 4% decrease compared to the prior year. GAAP diluted EPS was $1.58, while adjusted diluted EPS was $1.58 compared to $1.54 in the prior year. The company is withdrawing its fiscal year 2020 guidance due to COVID-19 uncertainties.

Nordson Corporation reported a slight decrease in sales for the first quarter of fiscal year 2020, with sales at $495 million compared to $498 million in the prior year. Diluted EPS was $0.89, including charges and benefits related to restructuring and tax items.